Moleculin Biotech (MBRX) Tops Q1 EPS by 209c
Tweet
Share
E-mailGet Alerts MBRX Hot Sheet
Join SI Premium – FREE
Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TON Strategy Company (TONX) Tops Q2 EPS by 264c
- Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c
- Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR) on Recent Acquisitions
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
